Concepedia

Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial

Yoshiya Tanaka, Damon Bass, Myron Chu, Sally Egginton, Beulah Ji, David A. Roth

Modern Rheumatology · 2019 · 13 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

Organ system improvements were seen in more Japanese belimumab-treated than placebo-treated patients, providing further evidence supporting belimumab use in Japanese patients with SLE.

References

26

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra, Renato Guzmán, A Gallacher et al. · The Lancet · 2011 · 2K citations

, , +11

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Richard Furie, Michelle Petri, Omid Zamani et al. · Arthritis & Rheumatism · 2011 · 1.7K citations · Full text

, , +17

Systemic Lupus Erythematosus

Anisur Rahman, David Isenberg · New England Journal of Medicine · 2008 · 1.6K citations

, , +17

Systemic lupus erythematosus

Caroline Gordon, Charles K. Li, David Isenberg · Medicine · 2010 · 571 citations

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

Ian N Bruce, Aidan G. O’Keeffe, Vernon T. Farewell et al. · Annals of the Rheumatic Diseases · 2014 · 566 citations · Full text

, , +17